Previous studies have confirmed the ability of ATOR to inhibit Bcl-2 and Caspase-3 expression thereby inhibiting glioma angiogenesis and ultimately inhibiting glioma cell progression [26]. Here, BCL2 is linked to central nervous system cancer.